time-to-event endpoint

17 papers; 17 titles.

Back to keywords

Conference ×	Year ×	Title ×	Authors	Extras	Pages
PharmaSUG CN	2026	Safety Estimands and Analysis Dataset Design: Advancing Safety Evaluation in Clinical Trials	Kun Ren, Zeyu Guang	source	11
PharmaSUG	2026	Algorithms to align the distribution of follow-up across independently collected cohorts when comparing time to event endpoints using conventional Kaplan Meier and Cox regression methods.	Shankar Srinivasan, Yvonne Buttkewitz, Regina Uttenreuther, Baldeep Chani Talwar, Manjari Dissanayake	source	12
PHUSE APAC	2026	Internal Paper AS19 Time-to-Event Analysis in Pain Management: A Case Study of the Double Stopwatch Method and ADaM Dataset Development in Relation to Rescue Medication	Arnode Mukherjee, Abhishek Paul	source presentation source	12
PHUSE EU	2025	One sample Log-Rank test for one sample survival studies: SAS code vs R code	Giulio Pacini, Menarini Ricerche, Giulia Tonini, Menarini Ricerche, Simona Scartoni, Menarini Ricerche	source presentation source	5
PharmaSUG	2025	Embracing an Extra Step as the Ultimate Shortcut: Leveraging ADDATES for Enhanced Efficiency and Traceability in Oncology Studies	Chia-Lu Lee, Wanchian Chen, Anna Chen	source	6
PharmaSUG	2025	Mastering the Maze of Oncology Endpoints: A Unified SAS Approach for Randomized Controlled Trial Analysis	Yuxin Wang, Kelly Chao, Wenqing Yu, Hongbing Jin	source	11
PharmaSUG	2025	Roadmap to Efficacy Analysis for Early Phase Oncology studies	Dhruv Bansal, Christiana Hawn, Chris Kelly	source	23
PharmaSUG	2024	ADaM Design for Prostate Cancer Efficacy Endpoints Based on PCWG3	Lihui Deng, Kylie Fan, Jia Li	source	10
PharmaSUG	2024	Reconstruction of Individual Patient Data (IPD) from Published Kaplan-Meier Curves Using Guyot-s Algorithm: Step-by-Step Programming in R	Ajay Gupta, Natalie Dennis	source	10
PHUSE US	2020	Assessing Non-inferiority and Equivalence from Survival Data	Chintan Arora, Parvee Kumar	source presentation source	7
PHUSE US	2018	ADaM Intermediate Dataset: How to Improve Your Analysis Traceability	Angelo Tinazzi, Ashish Aggarwal	source presentation source	12
PharmaSUG CN	2015	Use of SAS for Risk-Based Monitoring of Survival Endpoints and Adverse Event Data in Clinical Trials	Zhizhuo Zhang, Sichan Tang, Ka Chun Chong, Benny Chung-Ying Zee		5
PHUSE EU	2013	Efficacy Endpoints in Oncology	Angelo Tinazzi	source	9
PHUSE EU	2013	Interpreting CDISC ADaM IG Through Users Interpretation	Angelo Tinazzi	source presentation source	12
PharmaSUG	2013	Experiences in Preparing Summary Level Clinical Site Data within NDA's Submission for FDA's Inspection Planning	Xiangchen (Bob) Cui	source	19
PHUSE EU	2012	East6: Software for Designing, Simulating and Monitoring Group Sequential Trials	Hrishikesh Kulkarni, Sheetal Solanki	source presentation source	12
PHUSE EU	2008	A gentle introduction to Survival Analysis	Martin Scottt, Angelo Tinazzi	source	13

Back to keywords